Skip to main content
Top
Published in: BMC Ophthalmology 1/2017

Open Access 01-12-2017 | Research article

Absolute and estimated values of macular pigment optical density in young and aged Asian participants with or without age-related macular degeneration

Authors: Yoko Ozawa, Yuta Shigeno, Norihiro Nagai, Misa Suzuki, Toshihide Kurihara, Sakiko Minami, Eri Hirano, Hajime Shinoda, Saori Kobayashi, Kazuo Tsubota

Published in: BMC Ophthalmology | Issue 1/2017

Login to get access

Abstract

Background

Lutein and zeaxanthin are suggested micronutrient supplements to prevent the progression of age-related macular degeneration (AMD), a leading cause of blindness worldwide. To monitor the levels of lutein/zeaxanthin in the macula, macular pigment optical density (MPOD) is measured. A commercially available device (MPSII®, Elektron Technology, Switzerland), using technology based on heterochromatic flicker photometry, can measure both absolute and estimated values of MPOD. However, whether the estimated value is applicable to Asian individuals and/or AMD patients remains to be determined.

Methods

The absolute and estimated values of MPOD were measured using the MPSII® device in 77 participants with a best-corrected visual acuity (BCVA) > 0.099 (logMAR score).

Results

The studied eyes included 17 young (20–29 years) healthy, 26 aged (>50 years) healthy, 18 aged and AMD-fellow, and 16 aged AMD eyes. The mean BCVA among the groups were not significantly different. Both absolute and estimated values were measurable in all eyes of young healthy group. However, absolute values were measurable in only 57.7%, 66.7%, and 43.8%, of the aged healthy, AMD-fellow, and AMD groups, respectively, and 56.7% of the eyes included in the 3 aged groups. In contrast, the estimated value was measurable in 84.6%, 88.9% and 93.8% of the groups, respectively, and 88.3% of eyes in the pooled aged group. The estimated value was correlated with absolute value in individuals from all groups by Spearman’s correlation coefficient analyses (young healthy: R2 = 0.885, P = 0.0001; aged healthy: R2 = 0.765, P = 0.001; AMD-fellow: R2 = 0.851, P = 0.0001; and AMD: R2 = 0.860, P = 0.013). Using the estimated value, significantly lower MPOD values were found in aged AMD-related eyes, which included both AMD-fellow and AMD eyes, compared with aged healthy eyes by Student’s t-test (P = 0.02).

Conclusions

Absolute, in contrast to estimated, value was measurable in a limited number of aged participants; however, it was correlated with estimated value both in young and aged Asian populations with or without AMD. These results may inform future clinical studies investigating the measurement of MPOD in understanding the role of macular pigments in the pathogenesis of AMD.
Literature
1.
go back to reference Rein DB, Wittenborn JS, Zhang X, Honeycutt AA, Lesesne SB, Saaddine J. Vision health cost-effectiveness study G: forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments. Arch Ophthalmol. 2009;127(4):533–40.CrossRefPubMed Rein DB, Wittenborn JS, Zhang X, Honeycutt AA, Lesesne SB, Saaddine J. Vision health cost-effectiveness study G: forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments. Arch Ophthalmol. 2009;127(4):533–40.CrossRefPubMed
2.
go back to reference Yasuda M, Kiyohara Y, Hata Y, Arakawa S, Yonemoto K, Doi Y, Iida M, Ishibashi T. Nine-year incidence and risk factors for age-related macular degeneration in a defined Japanese population the Hisayama study. Ophthalmology. 2009;116(11):2135–40.CrossRefPubMed Yasuda M, Kiyohara Y, Hata Y, Arakawa S, Yonemoto K, Doi Y, Iida M, Ishibashi T. Nine-year incidence and risk factors for age-related macular degeneration in a defined Japanese population the Hisayama study. Ophthalmology. 2009;116(11):2135–40.CrossRefPubMed
3.
go back to reference Age-Related Eye Disease Study Research G. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119(10):1417–36.CrossRef Age-Related Eye Disease Study Research G. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119(10):1417–36.CrossRef
4.
go back to reference Age-Related Eye Disease Study 2 Research G. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the age-related eye disease study 2 (AREDS2) randomized clinical trial. JAMA. 2013;309(19):2005–15.CrossRef Age-Related Eye Disease Study 2 Research G. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the age-related eye disease study 2 (AREDS2) randomized clinical trial. JAMA. 2013;309(19):2005–15.CrossRef
5.
6.
go back to reference Nagai N, Izumi-Nagai K, Suzuki M, Shinoda H, Koto T, Uchida A, Mochimaru H, Tomita Y, Miyake S, Kobayashi S, et al. Association of macular pigment optical density with serum concentration of oxidized low-density lipoprotein in healthy adults. Retina. 2015;35(4):820–6.CrossRefPubMed Nagai N, Izumi-Nagai K, Suzuki M, Shinoda H, Koto T, Uchida A, Mochimaru H, Tomita Y, Miyake S, Kobayashi S, et al. Association of macular pigment optical density with serum concentration of oxidized low-density lipoprotein in healthy adults. Retina. 2015;35(4):820–6.CrossRefPubMed
7.
go back to reference Beatty S, Nolan J, Kavanagh H, O'Donovan O. Macular pigment optical density and its relationship with serum and dietary levels of lutein and zeaxanthin. Arch Biochem Biophys. 2004;430(1):70–6.CrossRefPubMed Beatty S, Nolan J, Kavanagh H, O'Donovan O. Macular pigment optical density and its relationship with serum and dietary levels of lutein and zeaxanthin. Arch Biochem Biophys. 2004;430(1):70–6.CrossRefPubMed
8.
go back to reference McKay GJ, Loane E, Nolan JM, Patterson CC, Meyers KJ, Mares JA, Yonova-Doing E, Hammond CJ, Beatty S, Silvestri G. Investigation of genetic variation in scavenger receptor class B, member 1 (SCARB1) and association with serum carotenoids. Ophthalmology. 2013;120(8):1632–40.CrossRefPubMedPubMedCentral McKay GJ, Loane E, Nolan JM, Patterson CC, Meyers KJ, Mares JA, Yonova-Doing E, Hammond CJ, Beatty S, Silvestri G. Investigation of genetic variation in scavenger receptor class B, member 1 (SCARB1) and association with serum carotenoids. Ophthalmology. 2013;120(8):1632–40.CrossRefPubMedPubMedCentral
9.
go back to reference Trieschmann M, Beatty S, Nolan JM, Hense HW, Heimes B, Austermann U, Fobker M, Pauleikhoff D. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study. Exp Eye Res. 2007;84(4):718–28.CrossRefPubMed Trieschmann M, Beatty S, Nolan JM, Hense HW, Heimes B, Austermann U, Fobker M, Pauleikhoff D. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study. Exp Eye Res. 2007;84(4):718–28.CrossRefPubMed
10.
go back to reference Obana A, Tanito M, Gohto Y, Okazaki S, Gellermann W, Bernstein PS. Changes in macular pigment optical density and serum Lutein concentration in Japanese subjects taking two different Lutein supplements. PLoS One. 2015;10(10):e0139257.CrossRefPubMedPubMedCentral Obana A, Tanito M, Gohto Y, Okazaki S, Gellermann W, Bernstein PS. Changes in macular pigment optical density and serum Lutein concentration in Japanese subjects taking two different Lutein supplements. PLoS One. 2015;10(10):e0139257.CrossRefPubMedPubMedCentral
11.
go back to reference Obana A, Tanito M, Gohto Y, Gellermann W, Okazaki S, Ohira A. Macular pigment changes in pseudophakic eyes quantified with resonance Raman spectroscopy. Ophthalmology. 2011;118(9):1852–8.CrossRefPubMed Obana A, Tanito M, Gohto Y, Gellermann W, Okazaki S, Ohira A. Macular pigment changes in pseudophakic eyes quantified with resonance Raman spectroscopy. Ophthalmology. 2011;118(9):1852–8.CrossRefPubMed
12.
go back to reference Obana A, Hiramitsu T, Gohto Y, Ohira A, Mizuno S, Hirano T, Bernstein PS, Fujii H, Iseki K, Tanito M, et al. Macular carotenoid levels of normal subjects and age-related maculopathy patients in a Japanese population. Ophthalmology. 2008;115(1):147–57.CrossRefPubMed Obana A, Hiramitsu T, Gohto Y, Ohira A, Mizuno S, Hirano T, Bernstein PS, Fujii H, Iseki K, Tanito M, et al. Macular carotenoid levels of normal subjects and age-related maculopathy patients in a Japanese population. Ophthalmology. 2008;115(1):147–57.CrossRefPubMed
13.
go back to reference Bernstein PS, Sharifzadeh M, Liu A, Ermakov I, Nelson K, Sheng X, Panish C, Carlstrom B, Hoffman RO, Gellermann W. Blue-light reflectance imaging of macular pigment in infants and children. Invest Ophthalmol Vis Sci. 2013;54(6):4034–40.CrossRefPubMedPubMedCentral Bernstein PS, Sharifzadeh M, Liu A, Ermakov I, Nelson K, Sheng X, Panish C, Carlstrom B, Hoffman RO, Gellermann W. Blue-light reflectance imaging of macular pigment in infants and children. Invest Ophthalmol Vis Sci. 2013;54(6):4034–40.CrossRefPubMedPubMedCentral
14.
go back to reference Bernstein PS, Zhao DY, Wintch SW, Ermakov IV, McClane RW, Gellermann W. Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients. Ophthalmology. 2002;109(10):1780–7.CrossRefPubMedPubMedCentral Bernstein PS, Zhao DY, Wintch SW, Ermakov IV, McClane RW, Gellermann W. Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients. Ophthalmology. 2002;109(10):1780–7.CrossRefPubMedPubMedCentral
15.
16.
go back to reference Sawa M, Gomi F, Hara C, Nishida K. Effects of a lutein supplement on the plasma lutein concentration and macular pigment in patients with central serous chorioretinopathy. Invest Ophthalmol Vis Sci. 2014;55(8):5238–44.CrossRefPubMed Sawa M, Gomi F, Hara C, Nishida K. Effects of a lutein supplement on the plasma lutein concentration and macular pigment in patients with central serous chorioretinopathy. Invest Ophthalmol Vis Sci. 2014;55(8):5238–44.CrossRefPubMed
17.
go back to reference Sasamoto Y, Gomi F, Sawa M, Sakaguchi H, Tsujikawa M, Nishida K. Effect of cataract in evaluation of macular pigment optical density by autofluorescence spectrometry. Invest Ophthalmol Vis Sci. 2011;52(2):927–32.CrossRefPubMed Sasamoto Y, Gomi F, Sawa M, Sakaguchi H, Tsujikawa M, Nishida K. Effect of cataract in evaluation of macular pigment optical density by autofluorescence spectrometry. Invest Ophthalmol Vis Sci. 2011;52(2):927–32.CrossRefPubMed
18.
go back to reference Bone RA, Landrum JT. Heterochromatic flicker photometry. Arch Biochem Biophys. 2004;430(2):137–42.CrossRefPubMed Bone RA, Landrum JT. Heterochromatic flicker photometry. Arch Biochem Biophys. 2004;430(2):137–42.CrossRefPubMed
19.
go back to reference van der Veen RL, Berendschot TT, Hendrikse F, Carden D, Makridaki M, Murray IJ. A new desktop instrument for measuring macular pigment optical density based on a novel technique for setting flicker thresholds. Ophthalmic Physiol Opt. 2009;29(2):127–37.CrossRefPubMed van der Veen RL, Berendschot TT, Hendrikse F, Carden D, Makridaki M, Murray IJ. A new desktop instrument for measuring macular pigment optical density based on a novel technique for setting flicker thresholds. Ophthalmic Physiol Opt. 2009;29(2):127–37.CrossRefPubMed
21.
go back to reference Xu J, Pokorny J, Smith VC. Optical density of the human lens. J Opt Soc Am A Opt Image Sci Vis. 1997;14(5):953–60.CrossRefPubMed Xu J, Pokorny J, Smith VC. Optical density of the human lens. J Opt Soc Am A Opt Image Sci Vis. 1997;14(5):953–60.CrossRefPubMed
22.
go back to reference Yamaguchi T, Negishi K, Dogru M, Saiki M, Tsubota K. Improvement of functional visual acuity after cataract surgery in patients with good pre- and postoperative spectacle-corrected visual acuity. J Refract Surg. 2009;25(5):410–5.CrossRefPubMed Yamaguchi T, Negishi K, Dogru M, Saiki M, Tsubota K. Improvement of functional visual acuity after cataract surgery in patients with good pre- and postoperative spectacle-corrected visual acuity. J Refract Surg. 2009;25(5):410–5.CrossRefPubMed
23.
go back to reference Tomita Y, Nagai N, Suzuki M, Shinoda H, Uchida A, Mochimaru H, Izumi-Nagai K, Sasaki M, Tsubota K, Ozawa Y. Functional visual acuity in age-related macular degeneration. Optom Vis Sci. 2016;93(1):70–6.PubMed Tomita Y, Nagai N, Suzuki M, Shinoda H, Uchida A, Mochimaru H, Izumi-Nagai K, Sasaki M, Tsubota K, Ozawa Y. Functional visual acuity in age-related macular degeneration. Optom Vis Sci. 2016;93(1):70–6.PubMed
24.
go back to reference Goto E, Yagi Y, Matsumoto Y, Tsubota K. Impaired functional visual acuity of dry eye patients. Am J Ophthalmol. 2002;133(2):181–6.CrossRefPubMed Goto E, Yagi Y, Matsumoto Y, Tsubota K. Impaired functional visual acuity of dry eye patients. Am J Ophthalmol. 2002;133(2):181–6.CrossRefPubMed
25.
go back to reference Nishi Y, Shinoda H, Uchida A, Koto T, Mochimaru H, Nagai N, Tsubota K, Ozawa Y. Detection of early visual impairment in patients with epiretinal membrane. Acta Ophthalmol. 2013;91(5):e353–7.CrossRefPubMed Nishi Y, Shinoda H, Uchida A, Koto T, Mochimaru H, Nagai N, Tsubota K, Ozawa Y. Detection of early visual impairment in patients with epiretinal membrane. Acta Ophthalmol. 2013;91(5):e353–7.CrossRefPubMed
26.
go back to reference Storey P, Munoz B, Friedman D, West S. Racial differences in lens opacity incidence and progression: the Salisbury eye evaluation (SEE) study. Invest Ophthalmol Vis Sci. 2013;54(4):3010–8.CrossRefPubMedPubMedCentral Storey P, Munoz B, Friedman D, West S. Racial differences in lens opacity incidence and progression: the Salisbury eye evaluation (SEE) study. Invest Ophthalmol Vis Sci. 2013;54(4):3010–8.CrossRefPubMedPubMedCentral
29.
go back to reference Kauppinen A, Paterno JJ, Blasiak J, Salminen A, Kaarniranta K. Inflammation and its role in age-related macular degeneration. Cell Mol Life Sci. 2016;73(9):1765–86.CrossRefPubMedPubMedCentral Kauppinen A, Paterno JJ, Blasiak J, Salminen A, Kaarniranta K. Inflammation and its role in age-related macular degeneration. Cell Mol Life Sci. 2016;73(9):1765–86.CrossRefPubMedPubMedCentral
Metadata
Title
Absolute and estimated values of macular pigment optical density in young and aged Asian participants with or without age-related macular degeneration
Authors
Yoko Ozawa
Yuta Shigeno
Norihiro Nagai
Misa Suzuki
Toshihide Kurihara
Sakiko Minami
Eri Hirano
Hajime Shinoda
Saori Kobayashi
Kazuo Tsubota
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2017
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-017-0557-5

Other articles of this Issue 1/2017

BMC Ophthalmology 1/2017 Go to the issue